Small Caps de Salud
Empresas pequeñas del sector salud — biotecnológicas, dispositivos médicos y servicios clínicos con riesgo regulatorio y alto potencial.
| Ticker | Empresa | Precio | Cap. Mercado | P/E | Crec. Ingr. | Potencial |
|---|---|---|---|---|---|---|
| ENSG | Ensign Group | $170.87 +2.42% | $9.99B | 27.8x | 18.4% | 29% |
| VIAV | Viavi Solutions | $40.22 -5.19% | $9.92B | — | 42.8% | 60.6% |
| TVTX | Travere Therapeutics | $57.85 +0.64% | $5.38B | — | 55.6% | 0.9% |
| STVN | Stevanato Group | $19.65 +1.92% | $5.36B | 33.9x | 6.6% | 24.4% |
| ALHC | Alignment Healthcare | $24.05 -2.08% | $4.97B | 240.5x | 33.3% | 3.6% |
| NVST | Envista Holdings | $27.15 -1.31% | $4.42B | 66.2x | 14.4% | 9.4% |
| MMSI | Merit Medical Systems | $72.14 +0.97% | $4.3B | 31.1x | 7.5% | 24.1% |
| IRTC | iRhythm Technologies | $125.09 -0.75% | $4.11B | — | 25.7% | 43% |
| CLDX | Celldex Therapeutics | $39.93 +5.22% | $3.13B | — | -97.8% | 44.1% |
| AGIO | Agios Pharmaceuticals | $44.01 +17.71% | $2.62B | — | 137.7% | -7.4% |
| LMAT | LeMaitre Vascular | $105.70 +1.91% | $2.42B | 39x | 11.2% | 12.4% |
| ADMA | ADMA Biologics | $9.21 +0.55% | $2.13B | 13.5x | 15.9% | 91.1% |
| NVCR | NovoCure | $17.72 +2.31% | $2.05B | — | 12.3% | 46.7% |
| OMCL | Omnicell | $44.36 -1.95% | $2.02B | 100.8x | 14.9% | 38.2% |
| ATEC | Alphatec Holdings | $9.38 +0.54% | $1.44B | — | 13.6% | 78.3% |
| XNCR | Xencor | $15.67 +5.24% | $1.16B | — | -86.2% | 81.9% |
| USPH | US Physical Therapy | $71.80 -2.15% | $1.09B | 143.6x | 7.9% | 30.5% |
| TNDM | Tandem Diabetes Care | $15.43 +0.06% | $1.06B | — | 5.5% | 87.1% |
| CNMD | Conmed Corporation | $34.24 -2.48% | $1.03B | 19.3x | -1.3% | 15.7% |
| INMD | InMode | $14.54 -0.41% | $835.8M | 10.8x | 5.3% | -1.4% |
| HSTM | HealthStream | $28.45 -2.13% | $831.2M | 42.5x | 10.5% | 12.5% |
| EOLS | Evolent Health | $6.94 -0.72% | $457M | — | 6.7% | 111.3% |
| TMCI | Treace Medical Concepts | $4.41 -3.29% | $286.1M | — | -10.2% | -9.3% |
| EMBC | Embecta Corp | $3.37 +2.74% | $199.9M | 1.8x | -14.4% | 18.7% |
| AMWL | Amwell | $8.99 -3.23% | $150.2M | — | -17.9% | -16.6% |
| TELA | Tela Bio | $0.89 +13.67% | $40M | — | 2.9% | 151.7% |
| CTSO | Cytosorbents Corporation | $0.41 -5.4% | $25.6M | — | 1.6% | 606.7% |
Análisis y Contexto
Este screener sectorial muestra actualmente 27 acciones del segmento seleccionado — actualizado diariamente. El P/E medio es de 59.3x. El crecimiento medio de ingresos es del 8.2%. Los sectores atraviesan fases cíclicas fuertemente correlacionadas con factores macroeconómicos — tipos de interés, crecimiento del PIB, precios de materias primas y entorno regulatorio impulsan la dinámica sectorial. Los analistas ven un potencial medio del 58.8% en estos valores. Compara las métricas con la media sectorial para identificar sobre- e infravaloraciones relativas. La concentración sectorial aumenta el riesgo de cartera — mantén una diversificación adecuada entre industrias y modelos de negocio.
¿Listo para invertir?
Compara los mejores brokers para acciones de EE.UU. y Europa — comisiones, plataformas y tipos de cuenta cara a cara.
Comparar brokers →